Brief: Acurx Pharmaceuticals Reports Q2 Loss Per Share Of $0.57
16/08/2021 22:12
Aug 16 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. REPORTS SECOND QUARTER 2021
RESULTS
AND PROVIDES BUSINESS UPDATE
* Q2 LOSS PER SHARE $0.57
* AS OF JUNE 30, 2021, COMPANY HAD A CASH BALANCE OF $17.1
MILLION
Source text for Eikon: ID:nPn74sQSha
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program